Wang Yongchun, Kowalski Jeanne, Tsai Hua-Ling, Marik Radharani, Prasad Nijaguna, Somervell Helina, Lo Pang-Kuo, Sangenario Lauren E, Dyrskjot Lars, Orntoft Torben F, Westra William H, Meeker Alan K, Eshleman James R, Umbricht Christopher B, Zeiger Martha A
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
Thyroid. 2008 Oct;18(10):1055-63. doi: 10.1089/thy.2008.0101.
Although fine-needle aspiration (FNA) biopsy of thyroid nodules is very sensitive in detecting thyroid malignancy, it remains ambiguous in 20-30% of cases. Current biomarkers for thyroid cancer lack either the sensitivity or specificity to substantially address this clinical problem. The aim of this study was to investigate the gene expression patterns of human telomerase reverse transcriptase (hTERT) alternative splice variants in benign and malignant thyroid tumors in an attempt to find a more reliable biomarker in the differential diagnosis of thyroid nodules.
One hundred and thirty-three thyroid tumors from eight histopathological tumor types were collected from patients undergoing thyroid surgery at Johns Hopkins Hospital. Gene expression patterns of hTERT alternative splice variants were investigated in the tumors by nested reverse transcriptase-PCR. Telomerase enzyme activity was evaluated in a subset of 16 samples associated with the different hTERT patterns. Association of c-myc expression and hTERT patterns was also examined.
Malignant thyroid tumors exhibited a greater proportion of the active full-length hTERT transcript (0.57 +/- 0.15) than inactive splice variants, alpha(-) (0.13 +/- 0.02), or beta(-)/alpha(-)beta(-) deletion transcripts (0.30 +/- 0.11; p < 0.001). The opposite was observed in benign tumors, which exhibited greater proportions of beta(-)/alpha(-)beta(-) deletion transcripts (0.64 +/- 0.08) than either the full-length (0.19 +/- 0.06) or alpha(-) deletion transcripts (0.17 +/- 0.02; p < 0.001). Similar results were observed among a diagnostically challenging subset of 50 thyroid tumors that were suspicious for malignancy on FNA. Further, increased telomerase enzymatic activity was only associated with expression of the full-length hTERT isoform. In contrast, c-myc expression, which has been implicated in hTERT regulation, correlated with overall hTERT transcription without specificity for expression of the full-length isoform.
These differences in gene expression patterns of hTERT alternative splice variants may provide a useful adjunct to FNA diagnosis of suspicious thyroid tumors.
尽管甲状腺结节细针穿刺(FNA)活检在检测甲状腺恶性肿瘤方面非常敏感,但在20%至30%的病例中结果仍不明确。目前用于甲状腺癌的生物标志物在敏感性或特异性方面均不足以实质性地解决这一临床问题。本研究的目的是调查人端粒酶逆转录酶(hTERT)可变剪接变体在良性和恶性甲状腺肿瘤中的基因表达模式,试图找到一种在甲状腺结节鉴别诊断中更可靠的生物标志物。
从约翰霍普金斯医院接受甲状腺手术的患者中收集了来自8种组织病理学肿瘤类型的133个甲状腺肿瘤。通过巢式逆转录聚合酶链反应(nested reverse transcriptase-PCR)研究肿瘤中hTERT可变剪接变体的基因表达模式。在与不同hTERT模式相关的16个样本子集中评估端粒酶活性。还检查了c-myc表达与hTERT模式的关联。
恶性甲状腺肿瘤中活性全长hTERT转录本的比例(0.57±0.15)高于无活性剪接变体α(-)(0.13±0.02)或β(-)/α(-)β(-)缺失转录本(0.30±0.11;p<0.001)。在良性肿瘤中观察到相反的情况,其β(-)/α(-)β(-)缺失转录本的比例(0.64±0.08)高于全长转录本(0.19±0.06)或α(-)缺失转录本(0.17±0.02;p<0.001)。在FNA检查怀疑为恶性的50个甲状腺肿瘤这一具有诊断挑战性的子集中也观察到了类似结果。此外,端粒酶活性增加仅与全长hTERT异构体的表达相关。相比之下,与hTERT调节有关的c-myc表达与整体hTERT转录相关,但对全长异构体的表达无特异性。
hTERT可变剪接变体基因表达模式的这些差异可能为FNA诊断可疑甲状腺肿瘤提供有用的辅助手段。